Overview
Toxoplasmosis is an infectious disease caused by a parasitic infection, Toxoplasma gondii. Toxoplasmosis can be acquired during pregnancy and can affect the fetus within the first three months.1 It is associated with another infectious disease known as TORCH, which has severe fetal complications to the mother and the baby at birth.2 Toxoplasmosis could lead to congenital toxoplasmosis in infants that can cause problems like hearing loss, seizures and vision problems.1 It causes complications during pregnancy like congenital infections, intrauterine fetal growth restriction and abortion.3 Toxoplasmosis equally harms the fetus while in the womb or at birth. However, if the infection starts later during pregnancy, the chances of the fetus or baby having any complications are greatly reduced.1
Toxoplasmosis is infectious, but during pregnancy, it's mostly asymptomatic (shows no symptoms). This is why regular screening and diagnostic tests are conducted during the first three months of pregnancy. It provides early diagnosis, detection and prompt treatment. This article will discuss the various screening and diagnostics for toxoplasmosis during pregnancy.
Understanding toxoplasmosis risk factors during pregnancy
It's obtained from eating food infected with the parasite:
- Eating undercooked meals
- Eating food that is not properly washed or kept in a hygienic environment
- Gardening in soil with cat faecal matter or gardening without gloves
- Cleaning the cat's litter box
- Drinking contaminated water
- Pregnant women with weak immune systems are at risk of contracting toxoplasmosis
Screening and diagnosis of toxoplasmosis during pregnancy
Serological testing and laboratory investigations primarily diagnose toxoplasmosis. Quick diagnosis is necessary to prevent toxoplasmosis from causing maternal and fetal complications. Let us discuss the various screening methods used to screen for toxoplasmosis.
Serological testing
This is the primary test that detects the presence of Toxoplasma gondii in the blood.
The test identifies toxoplasmosis even without symptoms. The test is used to determine if the mother has a recent or past toxoplasmosis infection.
It does this by identifying specific antibodies in the mother's blood. Antibodies, which are specialised proteins, fight against microorganisms, diseases and infections. The antibodies are IgM, IgA, IgG, and IgE:
- IgM can be detected one week after toxoplasmosis infection. It is an indicator for acute toxoplasmosis; the pregnant woman is infected but shows no symptoms.4 However, it remains detectable for several months or years. It could be tricky to rely on IgM antibody detection alone
- IgA is a crucial indicator of toxoplasmosis infection and occurs earlier than IgM. IgA could persist for a few months.
- IgG also indicates chronic toxoplasmosis infection, but there is no definite time for it. Chronic toxoplasmosis could have complications if not treated promptly. Though IgG detection has been used to identify chronic infection, there is no explicit way to differentiate between previous or recent infections4
We will discuss the tests used for screening and diagnosis.
Screening serological techniques
- Enzyme-linked immunosorbent assays (ELISA): this is a commonly used serological test to detect IgG and IgM.5 It is highly utilised due to its high sensitivity4
- Agglutination test: this test identifies only IgG antibodies and their concentration in the body
Screening may lead doctors to suspect toxoplasmosis in the pregnant mother. The best way to be sure before commencing treatment is a diagnostic test. Let us discuss them below:
Diagnostics (confirmatory) test techniques
- Dye test (DT): this test was considered a gold standard to identify toxoplasmosis in humans.6 It is specific and sensitive to the parasite. Though it requires live parasites, which makes it unsafe to carry out in a hospital setting and could be a biohazard. This test is performed more in a reference lab not easily accessible to the general public
- Indirect fluorescent antibody test (IFA): this test does not use live parasites. It makes it a safe and effective test. IgG and IgM antibodies are detected. IFA is highly sensitive and specific but may give a false positive result4
- Avidity test: this test measures the strength of IgG antibodies against toxoplasmosis infection. It also detects IgM antibodies. When an individual is infected with toxoplasmosis, the body first produces IgM antibodies but they quickly fade. IgG antibodies are produced later on and last for a couple of months or years. IgG antibodies last longer in the blood; it's not easy to detect if it's a current or previous infection. However, an avidity test is able to differentiate between a previous or current infection6
Molecular diagnostic test:
These tests are done to aid diagnosis made with serological tests. Serological tests are focused on the mother and if she has been exposed to toxoplasmosis. Molecular tests focus on the fetus and the risk forcongenital toxoplasmosis from the mother if she tested positive to toxoplasmosis.5
- Polymerase chain reactions (PCR): PCR focuses on the parasite DNA to diagnose toxoplasmosis.7 It is extremely sensitive, detecting even the lowest amount of T. gondii parasites. It can quantify the amount of T. gondii parasites from samples.7 The sample can be taken from blood, brain tissue, eyes or urine to obtain the DNA of T. gondii parasites for confirmation
Imaging techniques
These tests are done to provide visuals of the body. Imaging techniques like ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI) cannot diagnose toxoplasmosis. Rather, they aid to see if the body has been affected by complications from toxoplasmosis. Individuals with weakened immune systems, particularly HIV/AIDS, develop encephalitis (brain inflammation) and brain abscess. A CT scan or an MRI may be done to diagnose it and monitor if the medical treatments are working.6 CT scans are needed with babies at risk of congenital toxoplasmosis. It detects hydrocephalus (accumulation of cerebrospinal fluid in the brain) and intracranial calcifications (calcium deposits in the brain).6
Current guidelines and recommendations for screening
There are studies which present the current guidelines and screening for toxoplasmosis during pregnancy.
- Screening should be performed only for pregnant women at risk
- A serological screening test is the first screening method to undergo if the pregnant woman is at risk
- If toxoplasmosis has been confirmed for a pregnant woman, it should be confirmed again
- If a pregnant woman is infected with toxoplasmosis as an acute infection. A repeat test is done and treatment may start
- Amniocentesis (withdrawal of amniotic fluid from the womb) is performed between 4 and 18 weeks of gestation, only if the mother has been confirmed for toxoplasmosis infection. This is to reduce the occurrence of a false-negative result
- Pregnant women diagnosed with TORCH infections (toxoplasmosis, rubella, cytomegalovirus, herpes, and other infections) should take routine ultrasound screening. The fetus may be at risk of:
- Intracranial calcification (calcium deposits in the brain)
- Microcephaly (baby's head is smaller than expected)
- Hydrocephalus (baby's head is bigger than normal due to accumulation of cerebrospinal fluid in the brain)
- Ascites (collection of fluid in the belly)
- Hepatosplenomegaly (enlargement of the liver and spleen at the same time)
- Severe intrauterine growth restriction
- A pregnant woman who acquired toxoplasmosis during pregnancy must consult experts on toxoplasmosis treatment before commencing treatment
- Women who are living with a weakened immune system can take routine screening to avoid the risk of reactivation during pregnancy
- A woman diagnosed with toxoplasmosis should be advised to wait six months before she gets pregnant
- Toxoplasmosis prevention tips should be taught to all women who are pregnant or planning
Treatment and management of toxoplasmosis during pregnancy
The standard drugs for toxoplasmosis treatment are:
- Sulfadiazine with pyrimethamine
- Spiramycin
- Sulfamethoxazole with trimethoprim8
Pyrimethamine
This treatment only works on the tachyzoites (active form of the parasite) but will not work on the bradyzoites (dormant form of the parasite). Pyrimethamine is the first standard to treat toxoplasmosis. However, it lowers folic acid in the body and causes bone marrow suppression. Folinic acid is given to prevent bone marrow suppression.9
Sulfadiazine with pyrimethamine is not given in the first three months of pregnancy because it can harm the fetus. It is only administered when the fetus is confirmed to be infected.10
Spiramycin
Spriamycin does not affect the fetus and can be administered in the first three months. If the mother is diagnosed with toxoplasmosis or suspected, spiramycin is given to prevent fetal infection.10
Prevention tips for pregnant women
- Wash foods, fruits and vegetables properly
- Ensure foods and meats are well-cooked
- Use a gardening glove on each occasion
- Pregnant women who are ill shouldn't clean their cat litter boxes
- Avoid drinking water from unclear sources
- Eating raw seafood should be avoided
- Practice hand hygiene after gardening and before handling food items
- Kitchen items and utensils used for cooking meat or vegetables should be properly washed
Summary
Toxoplasmosis can affect pregnant mothers before and during pregnancy. It is important for pregnant mothers to understand the risk factors, consult their healthcare provider for management and understand the ways to prevent toxoplasmosis infection.
References
- Trotta M, Trotta A, Spataro E, Giache S, Borchi B, Zammarchi L, et al. Primary toxoplasmosis acquired during early pregnancy: Is it currently overestimated? European Journal of Obstetrics & Gynecology and Reproductive Biology [Internet]. 2021 Dec 1 [cited 2022 Oct 10];267:285–9. Available from: https://reader.elsevier.com/reader/sd/pii/S0301211521005649?token=AE6782B4D3BE40C0FF7AE9B1E8D65D148F5D5D7EAA61EC472F8F6312894D5A6EFB1BCC3495AA606440BB131A3BA2130E&originRegion=eu-west-1&originCreation=20221010090840
- Jaan A, Rajnik M. TORCH Complex [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560528/
- Kumar M, Saadaoui M, Al Khodor S. Infections and Pregnancy: Effects on Maternal and Child Health. Frontiers in Cellular and Infection Microbiology. 2022 Jun 8;12. Available from: https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2022.873253/full
- Ybañez RHD, Ybañez AP, Nishikawa Y. Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans. Frontiers in Cellular and Infection Microbiology. 2020 May 8;10. Available from: https://pubmed.ncbi.nlm.nih.gov/32457848/
- Teimouri A, Mahmoudi S, Behkar A, Sahebi K, Foroozand H, Hassanpour G, et al. Current and Emerging Techniques for Diagnosis of Toxoplasmosis in Pregnancy: A Narrative Review. Iranian journal of parasitology [Internet]. 2024;19(4):384–96. Available from: https://pubmed.ncbi.nlm.nih.gov/39735839/
- Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites & Vectors [Internet]. 2015 May 28;8(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451882/
- Kim MJ, Park SJ, Park H. Trend in serological and molecular diagnostic methods for Toxoplasma gondii infection. European journal of medical research. 2024 Oct 28;29(1).
- Cristiana-Elena Durdu, Roxana-Elena Bohîlțea. Toxoplasmosis and Pregnancy: Current Approaches for Favourable Fetal Outcome. 2023 Sep 1 [cited 2025 Aug 27];2(3):12–21. Available from: https://www.mdpi.com/3091-101X/2/3/17
- CDC. Clinical Care of Toxoplasmosis [Internet]. Toxoplasmosis. 2024. Available from: https://www.cdc.gov/toxoplasmosis/hcp/clinical-care/index.html
- Chaudhry SA, Gad N, Koren G. Toxoplasmosis and pregnancy. Canadian Family Physician [Internet]. 2014 Apr;60(4):334. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4046541/

